Restart Life Sciences Corp (HEAL.CX)
0.04
0.00 (0.00%)
CAD |
CNSX |
Nov 12, 13:31
Restart Life Sciences Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 0.0283M |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.0015M |
September 30, 2020 | 0.0013M |
June 30, 2020 | 0.0017M |
March 31, 2020 | 0.0069M |
December 31, 2019 | 0.0072M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0013M
Minimum
Sep 2020
0.0283M
Maximum
Sep 2023
0.0078M
Average
0.0043M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -0.0906M |
Total Expenses (Quarterly) | 0.0908M |
EPS Diluted (Quarterly) | -0.0031 |
Enterprise Value | 1.234M |
Earnings Yield | -61.20% |
Normalized Earnings Yield | -145.28 |